Atorvastatin vs Rosuvastatin: Which High-Intensity Statin Is Better for You?

Atorvastatin and rosuvastatin are both considered “high-intensity” statins because, at the right dose, each can lower low-density lipoprotein cholesterol (LDL-C) by at least 50 percent. Rosuvastatin is more potent milligram-for-milligram and has slightly fewer drug-interaction concerns, while atorvastatin has the longest track record for preventing heart attacks and is often a few dollars cheaper as a generic. Either drug can hit guideline targets; the better choice depends on your LDL goal, other medicines, liver and kidney health, and how price-sensitive you are.

• Rosuvastatin 10 mg lowers LDL-C by about 52 percent, roughly the same drop achieved with atorvastatin 40 mg. (DailyMed Crestor PI)
• The elimination half-life is 19 hours for rosuvastatin and 14 hours for atorvastatin, so both can be taken morning or night without affecting efficacy. (DailyMed Lipitor PI)
• Atorvastatin is metabolized by CYP3A4, meaning clarithromycin, certain antifungals and grapefruit juice can raise levels; rosuvastatin is minimally metabolized and uses transporter pathways instead. (StatPearls Rosuvastatin)
• According to the July 2026 CMS NADAC file, most retail pharmacies acquire generic atorvastatin 40 mg for about $0.05 per tablet and rosuvastatin 20 mg for about $0.07. (CMS NADAC 2026)

What Atorvastatin and Rosuvastatin Are

Statins are HMG-CoA reductase inhibitors that slow cholesterol production in the liver and up-regulate LDL receptors so more LDL-C is cleared from the bloodstream. Atorvastatin is marketed under the brand Lipitor ® and was FDA-approved in 1996; rosuvastatin, sold as Crestor ®, gained approval in 2003. Both are now widely available as low-cost generics: atorvastatin-calcium and rosuvastatin-calcium.

Definition: High-intensity statin therapy is any daily statin dose proven to lower LDL-C by 50 percent or more. Current American Heart Association guidelines list atorvastatin 40–80 mg or rosuvastatin 20–40 mg as high-intensity options.

Because both drugs achieve similar LDL reductions, the choice usually comes down to potency per milligram, interaction profile, kidney considerations and out-of-pocket cost.

How These Statins Lower Cholesterol

Both medicines block the rate-limiting step of cholesterol synthesis, but there are subtle pharmacologic differences.

Lipophilicity vs hydrophilicity: Atorvastatin is moderately lipophilic, which allows more penetration into non-hepatic tissues. Rosuvastatin is hydrophilic and more liver-selective, potentially explaining its lower rate of central nervous system side effects.

Metabolic pathways: Atorvastatin is extensively metabolized by CYP3A4, while rosuvastatin undergoes minimal CYP metabolism (about 10 percent via CYP2C9) and is instead transported by OATP1B1 and BCRP proteins (ncbi.nlm.nih.gov). The difference means fewer interaction warnings for rosuvastatin.

How Effective Are They? Head-to-Head Numbers

The table below shows average LDL-C reductions observed in pivotal dose-response trials submitted to the FDA for each drug.

Data sources: Atorvastatin Table 6, Lipitor prescribing information (dailymed.nlm.nih.gov); Rosuvastatin Table 10, Crestor prescribing information (dailymed.nlm.nih.gov).

Takeaway: Rosuvastatin achieves the same LDL reduction at roughly half the milligram dose of atorvastatin, but clinical outcome benefits have been demonstrated robustly for both drugs.

Half-Life, Timing and Dose Flexibility

Because both statins have half-lives over 14 hours, you do not have to take them at night. Morning, afternoon or bedtime dosing all produce similar LDL drops (dailymed.nlm.nih.gov). If you already take multiple morning pills, adding your statin then may improve adherence.

Renal considerations: Rosuvastatin is partially renally cleared. The manufacturer recommends starting at 5 mg and avoiding 40 mg in patients with estimated GFR <30 mL/min/1.73 m². Atorvastatin requires no dose change in renal impairment (dailymed.nlm.nih.gov).

Both tablets can be split if your pharmacist confirms the product is scored, which may stretch a 40 mg pill into two 20 mg doses when titrating.

Drug-Drug Interactions to Know

CYP3A4 inhibitors: Clarithromycin, azole antifungals, HIV protease inhibitors and even large amounts of grapefruit juice can double or triple atorvastatin blood levels, raising the risk of muscle toxicity. Rosuvastatin levels are largely unaffected because the drug is not a CYP3A4 substrate.

Bile-acid sequestrants: All statins should be given at least two hours before or four hours after cholestyramine or colesevelam to avoid binding in the gut.

Warfarin: Rosuvastatin can increase INR slightly; monitor more closely during the first month.

Gemfibrozil: Combination with either statin is discouraged because of additive muscle-toxicity risk, but especially with rosuvastatin 40 mg (dailymed.nlm.nih.gov).

For a full list, review the FDA package insert or talk with your pharmacist.

Side-Effect Profiles: Myalgia, Liver and Glucose

Randomized trials report muscle pain in about 2–5 percent of users of either drug, a rate similar to placebo (pmc.ncbi.nlm.nih.gov). True rhabdomyolysis is rare (≈1 per 10,000 patients-years).

Liver enzymes: ALT elevations >3× ULN occur in roughly 0.5 percent of patients on atorvastatin 80 mg and 0.4 percent on rosuvastatin 40 mg. Baseline and follow-up LFTs at 6–12 weeks are standard.

New-onset diabetes: A meta-analysis suggests one new diabetes case for every 255 patients treated for four years with intensive-dose statin therapy; risk appears similar between the two drugs.

Cost Comparison and Savings Tips

Even tiny price differences add up over years of therapy. July 2026 CMS NADAC acquisition costs (what pharmacies pay wholesalers) are shown below.

*Retail mark-ups vary widely. Always run both drugs through the Rx.com price comparison tool at your preferred pharmacy.

Insurance formularies usually place both statins on the lowest tier. However, if your plan uses step therapy, starting with generic atorvastatin may help you avoid prior authorization.